Alexion has gained FDA approval for Kanuma, its treatment for the rare disease lysosomal acid lipase (LAL) deficiency. Alexion says Kanuma (sebelipase alfa) could eventually bring in more than $ ...
Meanwhile, AZ will also picks up three other drugs – Strensiq (asfotase alfa) for hypophosphatasia, Kanuma (sebelipase alfa) for lysosomal acid lipase deficiency (LAL-D) and anticoagulant ...
[66] One can postulate that antiproteases might protect the mammary gland from local proteolysis (caused by leukocytic or lysosomal proteases ... and digestive lipase) act in the newborn to ...
Researchers have identified a potential treatment for Sandhoff and Tay-Sachs diseases -- two rare, often fatal lysosomal storage disorders that cause progressive damage to nerve cells in the brain and ...
In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...
Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...
Symptoms of high stomach acid can include belly pain, bloating, and heartburn. They can be caused by bacterial infections, stress, and rebound effects from medication withdrawal. Stomach acid is ...
Oxidative Stress: Neuropathy, Excitability, and Neurodegeneration.
Researchers from the US discovered a novel epitope in the E2 subunit of the mitochondrial pyruvate dehydrogenase complex (PDC-E2).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback